感覚受容体を除くGPCRをヒト 300種、マウス 250種、計550種取り揃え、共役するGαタンパク質のサブタイプに依らず単一フォーマットの高感度アッセイで活性を評価します。パネル試験、濃度依存性解析など様々な試験フォーマットでオーファンGPCRを含む幅広い受容体の解析が可能です。各受容体の詳細は表をクリックしてください。また、ラット、ウサギ、イヌ、カニクイザルなど他生物種のGPCRについてはお問い合わせください。
Filters Sort results
Reset Apply
Species | Receptor | Family | Assays | |
|---|---|---|---|---|
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 13 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 4.0 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 2.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 3.2 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 3.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.9 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 2.5 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 26 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 85 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 8.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 310 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 110 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 31 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 47 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 5.9 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 4.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 11 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 19 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 1.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 18 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 28 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 67 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 71 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 33 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 89 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 22 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 26 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 47 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: angiotensin ⅠⅠ EC50: 920 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: apelin‐13 EC50: 8.1 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: TGR5 agonist EC50: 350 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: bombesin EC50: 2.4 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: GRP EC50: 1.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NMB EC50: 590 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: calcitonin EC50: 2.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CGRP EC50: 1.0 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: cinacalcet EC50: 140 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CP55940 EC50: 640 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CP55940 EC50: 2.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: LPI EC50: 1.2 µM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: N‐oleoylethanolamine EC50: 6.3 µM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: chemerin EC50: 15 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL3 EC50: 250 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL2 EC50: 1.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL22 EC50: 20 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL4 EC50: 7.1 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL20 EC50: 3.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL21 EC50: 15 nM |
お問い合わせ
当社担当者と直接コミュニケーションを取りながら、目的に応じた試験デザインを検討していただくことができます。「まずは試験系について説明を受けたい」「どのような試験デザインが可能か検討したい」「他の動物種のGPCRも試験可能か」といった計画段階のご相談も歓迎しており、電話やウェブ会議で無料相談を行っています。まずはこちらのフォームかメールにてご連絡下さい。24時間以内にお返事いたします。
試験委託の流れ
見積り依頼
ご希望、目的に適した試験と価格をご提案します。
STEP
1
発注
試験受委託契約を締結して頂きます。秘密保持契約も可能です。
STEP
2
化合物送付
当社宛に化合物をお送り頂きます。
STEP
3
報告書受領
試験開始から通常3週間後に結果報告書と生データを電子メールでお送りします。
STEP
4